• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ascites in Ovarian Carcinoma - Reliability and Limitations of Cytological Analysis.卵巢癌中的腹水——细胞学分析的可靠性与局限性
West Indian Med J. 2015 Jun;64(3):236-40. doi: 10.7727/wimj.2014.230. Epub 2015 Apr 8.
2
Applications of the telomerase assay in peritoneal washing fluids.端粒酶检测在腹腔冲洗液中的应用。
Gynecol Oncol. 2001 Jun;81(3):420-3. doi: 10.1006/gyno.2001.6174.
3
False-negative peritoneal cytology in metastatic ovarian carcinoma.转移性卵巢癌中腹膜细胞学检查假阴性
Obstet Gynecol. 1986 Nov;68(5):619-23.
4
Study of effusion cytology in patients with simultaneous malignancy and ascites.同时患有恶性肿瘤和腹水患者的积液细胞学研究
Kathmandu Univ Med J (KUMJ). 2006 Oct-Dec;4(4):483-7.
5
Assessment of False-negative Ascites Cytology in Epithelial Ovarian Carcinoma: A Study of 313 Patients.上皮性卵巢癌假阴性腹水细胞学评估:313例患者的研究
Am J Clin Oncol. 2017 Apr;40(2):175-177. doi: 10.1097/COC.0000000000000119.
6
Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma.
Obstet Gynecol. 1988 Jun;71(6 Pt 1):851-3.
7
Detection of allelic imbalance in ascitic supernatant by digital single nucleotide polymorphism analysis.
Clin Cancer Res. 2002 Aug;8(8):2580-5.
8
Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.血管内皮生长因子在卵巢癌腹膜播散过程中激活腹水中的基质金属蛋白酶。
Oncol Rep. 2003 Jan-Feb;10(1):89-95.
9
Role of peritoneal washing cytology in ovarian malignancies: correlation with histopathological parameters.腹腔冲洗液细胞学检查在卵巢恶性肿瘤中的作用:与组织病理学参数的相关性
World J Surg Oncol. 2015 Nov 10;13:315. doi: 10.1186/s12957-015-0732-1.
10
Diagnostic Impact of Peritoneal Fluid Cytology in the Setting of Pediatric Uterine Adnexal Biopsy or Resection.小儿子宫附件活检或切除术中腹腔液细胞学检查的诊断意义
Pediatr Dev Pathol. 2016 Sep/Oct;19(5):401-408. doi: 10.2350/15-10-1716-OA.1. Epub 2015 Nov 18.

引用本文的文献

1
DNA Repair Protein HELQ and XAB2 as Chemoresponse and Prognosis Biomarkers in Ascites Tumor Cells of High-Grade Serous Ovarian Cancer.DNA修复蛋白HELQ和XAB2作为高级别浆液性卵巢癌腹水肿瘤细胞化疗反应和预后生物标志物
J Oncol. 2022 Mar 29;2022:7521934. doi: 10.1155/2022/7521934. eCollection 2022.
2
Targeted Sequencing of Ascites and Peritoneal Washing Fluid of Patients With Gastrointestinal Cancers and Their Clinical Applications and Limitations.胃肠道癌患者腹水及腹腔冲洗液的靶向测序及其临床应用与局限性
Front Oncol. 2021 Jul 15;11:712754. doi: 10.3389/fonc.2021.712754. eCollection 2021.
3
Diffusion-Weighted Magnetic Resonance Imaging as a Noninvasive Parameter for Differentiating Benign and Malignant Intraperitoneal Collections.扩散加权磁共振成像作为一种无创参数,用于区分良性和恶性腹腔积液。
Medicina (Kaunas). 2020 May 1;56(5):217. doi: 10.3390/medicina56050217.
4
Role of the body mass index in the genesis of ascites in ovarian cancer: a forensic case and review of the literature.体重指数在卵巢癌腹水形成中的作用:一例法医案例及文献综述
BMJ Case Rep. 2018 Dec 18;11(1):e226491. doi: 10.1136/bcr-2018-226491.
5
Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer.新辅助化疗后腹水消退对 IIIc 至 IV 期高级别浆液性卵巢癌治疗结局的预测作用
J Ovarian Res. 2016 Dec 2;9(1):85. doi: 10.1186/s13048-016-0294-z.

本文引用的文献

1
Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures.恶性腹水:预后因素、病理生理学和治疗措施的综述。
World J Gastrointest Surg. 2012 Apr 27;4(4):87-95. doi: 10.4240/wjgs.v4.i4.87.
2
Challenges in the interpretation of peritoneal cytologic specimens.腹膜细胞学标本解读中的挑战。
Arch Pathol Lab Med. 2009 May;133(5):739-42. doi: 10.5858/133.5.739.
3
Malignant ascites: systematic review and guideline for treatment.恶性腹水:系统评价与治疗指南
Eur J Cancer. 2006 Mar;42(5):589-97. doi: 10.1016/j.ejca.2005.11.018. Epub 2006 Jan 24.
4
Monoclonal antibody MOC-31 reactivity as a marker for adenocarcinoma in cytologic preparations.单克隆抗体MOC-31反应性作为细胞学标本中腺癌的标志物
Cancer. 2006 Feb 25;108(1):56-9. doi: 10.1002/cncr.21426.
5
Malignant ascites: past, present, and future.恶性腹水:过去、现在与未来
J Am Coll Surg. 2004 Jun;198(6):999-1011. doi: 10.1016/j.jamcollsurg.2004.01.035.
6
How valuable is ascitic cytology in the detection and management of malignancy?腹水细胞学检查在恶性肿瘤的检测和管理中有多大价值?
Postgrad Med J. 2003 May;79(931):292-4. doi: 10.1136/pmj.79.931.292.
7
Ascites as a predictor of ovarian malignancy.腹水作为卵巢恶性肿瘤的一个预测指标。
Gynecol Oncol. 2002 Oct;87(1):77-83. doi: 10.1006/gyno.2002.6800.
8
Malignant ascites: demographics, therapeutic efficacy and predictors of survival.恶性腹水:人口统计学、治疗效果及生存预测因素
Can J Oncol. 1996 Nov;6(2):474-80.
9
Peritoneal washing cytology of ovarian tumors of low malignant potential: correlation with surface ovarian involvement and peritoneal implants.低恶性潜能卵巢肿瘤的腹腔冲洗液细胞学检查:与卵巢表面受累及腹膜种植的相关性
Acta Cytol. 1998 Sep-Oct;42(5):1091-4. doi: 10.1159/000332094.
10
Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination.卵巢癌细胞的检测:端粒酶检测与细胞学检查的比较
J Natl Cancer Inst. 1998 Feb 4;90(3):238-42. doi: 10.1093/jnci/90.3.238.

卵巢癌中的腹水——细胞学分析的可靠性与局限性

Ascites in Ovarian Carcinoma - Reliability and Limitations of Cytological Analysis.

作者信息

Živadinović R, Petrić A, Krtinić D, Stevanović Milosević J, Pop Trajković Dinić S

机构信息

Clinic for Gynaecology and Obstetrics, Clinical Centre Nis, Serbia.

Faculty of Medicine, University of Nis, Serbia.

出版信息

West Indian Med J. 2015 Jun;64(3):236-40. doi: 10.7727/wimj.2014.230. Epub 2015 Apr 8.

DOI:10.7727/wimj.2014.230
PMID:26426176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4763898/
Abstract

OBJECTIVE

The objective of this study was to examine the validity of ascitic fluid cytology in the detection of pathological findings, to examine the percentage of false positive and false negative results in the cytology of ascitic fluid and to determine the validity of peritoneal cytology in relation to the histopathological type of the ovarian tumour.

METHODS

This retrospective study included 170 peritoneal cytology findings. The study was conducted from January 2010 to December 2012. The experimental group included 76 cytology findings obtained from patients diagnosed with ovarian carcinoma, whereas the control group was composed of 94 cytology findings of benign ovarian tumours and liver cirrhosis ascites. The patients with ovarian carcinoma had grades III, as well as grades I and IIc but only in cases where operative and pathological finding indicated a ruptured or perforated tumour capsule.

RESULTS

The sensitivity of peritoneal cytology is 68.92%, specificity is 93.61%, positive predictive value is 89.65% and negative predictive value is 78.57%. In 30.02% of patients, the peritoneal cytology showed false negative results, while in 6.38%, the results were false positive. The highest percentage of false negative findings was 77%, found in endometrioid carcinoma.

CONCLUSION

Peritoneal cytology of ascitic fluid is highly specific but has relatively low sensitivity, particularly in the case of endometrioid ovarian carcinoma. In order to increase sensitivity, peritoneal cytology should be combined with monoclonal antibodies and other biochemical and immunohistochemical markers.

摘要

目的

本研究的目的是检验腹水细胞学在检测病理结果方面的有效性,检查腹水细胞学假阳性和假阴性结果的百分比,并确定腹膜细胞学与卵巢肿瘤组织病理学类型的相关性。

方法

这项回顾性研究纳入了170例腹膜细胞学检查结果。研究时间为2010年1月至2012年12月。实验组包括从诊断为卵巢癌的患者中获得的76例细胞学检查结果,而对照组由94例良性卵巢肿瘤和肝硬化腹水的细胞学检查结果组成。卵巢癌患者为III级,以及I级和IIc级,但仅限于手术和病理结果显示肿瘤包膜破裂或穿孔的病例。

结果

腹膜细胞学的敏感性为68.92%,特异性为93.61%,阳性预测值为89.65%,阴性预测值为78.57%。在30.02%的患者中,腹膜细胞学显示假阴性结果,而在6.38%的患者中,结果为假阳性。假阴性结果的最高百分比为77%,见于子宫内膜样癌。

结论

腹水的腹膜细胞学具有高度特异性,但敏感性相对较低,尤其是在子宫内膜样卵巢癌的情况下。为了提高敏感性,腹膜细胞学应与单克隆抗体及其他生化和免疫组化标志物联合使用。